Loading data for ATRC — first visit, this takes a few seconds.

AtriCure, Inc. (ATRC)

NasdaqGM: ATRC · 即時價格 · USD

48.54

-0.73 (-1.48%)

收盤價： Sep 04, 2026, 8:00 PM

53.12

+3.11%

盤後: 7:30 PM

提醒

Alert

股價、關鍵數字和最新消息，都在這一頁。

無可用資料

買價	27.83
市值	2.62B
營收 (ttm)	570M
淨利（ttm）	10.6M
	1.26
	0.21
	245.33
	119.33
P/B (ttm)	5.07
P/S (ttm)	4.60
財報日期	May 5, 2026

賣價	49.7
成交量	390,632
20 日平均成交量	894,698
開盤價	49.50
前收盤價	49.27
當日區間	48.35 - 49.98
52 週範圍	25.36 - 49.98
分析師	n/a
目標價	n/a
股利	n/a
除息日	n/a

關於 ATRC

AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally. It offers Isolator Synergy Ablation System clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, a ...

[閱讀更多]

產業 Medical Instruments & Supplies

類股 Healthcare

IPO 日期 Aug 5, 2005

員工 1,350

證券交易所 NasdaqGM

股票代號 ATRC

網站 https://www.atricure.com

完整的公司簡介

財務表現

AtriCure 在 2025 年的營收為 534.53M，較前一年的 465.31M 增加 14.88%。淨利為 -11.45M，較前期減少 -74.39%。

財務報表

財報驚奇

AtriCure 已於 Jul 23, 2026 公布季度財報：

營收為 $153.6M 低於預期 $0, 年增 12.83% 成長.
每股盈餘為 0.18 超出預期 0.16, 年增 228.57% 成長.

下次財報發布

AtriCure, Inc. 的下次財報預計於 May 5, 2026, 收盤後。
分析師預估營收 ... 升級

價格為何變動

新聞動態

2 週前 · Zacks

Is AtriCure (ATRC) Outperforming Other Medical Stocks This Year?

Here is how AtriCure (ATRC) and Aveanna Healthcare (AVAH) have performed compared to their sector so far this year.

1 月前 · MarketBeat

AtriCure Targets $1 Billion as Pain Management and AFib Trials Fuel Growth

AtriCure (NASDAQ:ATRC) said it is seeing continued growth across its atrial fibrillation, left atrial appendage management and postsurgical pain-management businesses, supported by new product adoptio...

1 月前 · Motley Fool

Two AtriCure Directors Trimmed Shares After a Strong Quarter. Here's What Matters for Investors

The sale came at $38.42 per share, slightly below the day's market close, as AtriCure maintains its $2.0 billion market cap in the medical device sector.

1 月前 · Motley Fool

An AtriCure Director Sold $905,000 in Stock. Here's How to Read It

Prange's open-market disposition reduced her direct holdings by 14%, though she retains over 22,800 shares in the $2.0 billion medical device company.

1 月前 · Simply Wall St.

Project Horizon and Outlook Upgrade Might Change The Case For Investing In Inspire Medical Systems (INSP)

Inspire Medical Systems recently appointed AtriCure CEO Michael H. Carrel to its Board and committees, while long-serving director Casey M. Tansey plans to retire, as the company reported quarterly re...

第 1 頁，共 2 頁

AtriCure, Inc. (ATRC)